These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16160009)

  • 1. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.
    Sahni A; Khorana AA; Baggs RB; Peng H; Francis CW
    Blood; 2006 Jan; 107(1):126-31. PubMed ID: 16160009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a binding site on human FGF-2 for fibrinogen.
    Peng H; Sahni A; Fay P; Bellum S; Prudovsky I; Maciag T; Francis CW
    Blood; 2004 Mar; 103(6):2114-20. PubMed ID: 14630795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2.
    Sahni A; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1271-7. PubMed ID: 12871330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3.
    Sahni A; Francis CW
    Blood; 2004 Dec; 104(12):3635-41. PubMed ID: 15297314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2.
    Sahni A; Sporn LA; Francis CW
    J Biol Chem; 1999 May; 274(21):14936-41. PubMed ID: 10329694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth.
    Sahni A; Altland OD; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1304-10. PubMed ID: 12871334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
    Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form.
    Sahni A; Guo M; Sahni SK; Francis CW
    Blood; 2004 Jul; 104(2):409-14. PubMed ID: 15039285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity.
    Liu Z; Liu G; Zhang GL; Li J; He YQ; Zhang SS; Wang Y; He WY; Cheng GH; Yang X; Xu J; Wang J
    Oncotarget; 2016 Oct; 7(42):68473-68488. PubMed ID: 28049184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
    Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
    Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis.
    Bae YH; Park HJ; Kim SR; Kim JY; Kang Y; Kim JA; Wee HJ; Kageyama R; Jung JS; Bae MK; Bae SK
    Cardiovasc Res; 2011 Feb; 89(2):436-45. PubMed ID: 20817637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.
    Forough R; Weylie B; Collins C; Parker JL; Zhu J; Barhoumi R; Watson DK
    J Vasc Res; 2006; 43(4):327-37. PubMed ID: 16682805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin induces the expression of FGF2 but does not synergize with it during angiogenesis.
    Krishnapati LS; Ghaskadbi S
    Microvasc Res; 2016 Jan; 103():55-63. PubMed ID: 26549747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo.
    Bai Y; Leng Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
    Cell Tissue Res; 2014 Apr; 356(1):109-21. PubMed ID: 24442492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo.
    Lin X; Takahashi K; Campion SL; Liu Y; Gustavsen GG; Peña LA; Zamora PO
    Int J Mol Med; 2006 May; 17(5):833-9. PubMed ID: 16596268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.
    Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K
    FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.
    Matsumoto T; Turesson I; Book M; Gerwins P; Claesson-Welsh L
    J Cell Biol; 2002 Jan; 156(1):149-60. PubMed ID: 11781339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.